AlphAIalphai — Financial news for AI agents
simplywall.stAUG 222 min read$DK

Delek US Holdings (DK) After Strong Q2 Results Is The Recovery Story Already Priced In

Delek US Holdings (DK) reported strong Q2 results, driven by refining margins and improved output. The stock has surged 63.62% over 90 days and 198.61% over a year. Analysts note it trades above fair value estimates, with concerns about overvaluation and risks like net losses and high capital spending. The company expects $130–$170 million in annualized cash flow improvements by 2025.

Original reporting
simplywall.st
Published Aug 22, 2026, 1:38 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 12:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Delek US Holdings (DK) After Strong Q2 Results Is The Recovery Story Already Priced In — source image
Source · simplywall.st
Decision brief

The 30-second read

$DKNeutralLow
01

Why it matters

The article offers no new financial metrics, serving mainly as a recap and valuation opinion.

02

Market read

Reinforces existing bullish narrative but adds little actionable insight.

03

What to watch

Potential regulatory or commodity price volatility not addressed.

Relevance 4/10Novelty 2/10Timing: post‑Q2 commentary

Background

Simply Wall St provides a fundamental‑focused commentary on Delek US Holdings after its Q2 update.

Company-level read

Ticker impact

$DKNeutralMedium confidence
Context

Article discusses Delek US Holdings' Q2 performance and valuation, making the stock the subject.

Expected impact

Limited impact; price may stay range‑bound as investors reassess valuation.

Evidence & confidence

The piece recaps known Q2 results without fresh numbers, so any price move would be modest.

Market effects

Sector

Highlights refining margin recovery, but no sector‑wide catalyst.

Regional

U.S. energy sector may see modest attention.

Global

Limited; focus is on a single U.S. refiner.

Counterpoint

What could challenge this read

Despite strong Q2, high capital spending and net losses could pressure the stock.

Key entities

  • company
    Delek US Holdings

    U.S. refining company discussed in the article.

Read at source← All news

Related articles

AUG 24
$DKMed

Is DK a Buy Now as Cash Flow Improves Despite Refining Cycle Risks?

Delek US Holdings (DK) reported improved cash flow in Q2, with $262.9M from operations. Management expects $220M annual free-cash-flow improvement. DK trades at a forward P/E of 7.1 and P/S of 0.36. Risks include leverage, crack-spread volatility, and regulatory uncertainty. Zacks ranks DK as a Strong Buy with A-rated Value and Growth scores.

tradingview.com3 min
AUG 23
$DKMedAI 8/10

Up another 12% Friday, this AI-picked energy stock is now up +90%

Delek US Holdings (DK) surged 11.6% on Friday, reaching near a 52-week high of $71.47, extending its 90% gain since March. The energy company reported Q2 EPS of $5.48, beating estimates by 148%, with EBITDA up 279% quarter-over-quarter. InvestingPro's AI models identified Delek's potential before its rally, citing strong momentum, earnings turnaround, and cost discipline. The company's performance highlights include record refining margins and operational improvements. InvestingPro members recei

investing.com2 min
AUG 22
$DKHighAI 8/10

DK Surges As Delek US Earnings Smash Wall Street Targets

Delek US Holdings Inc. (DK) stock surged 11.54% after Q2 earnings beat expectations, with revenue of $4.09B and adjusted EPS up to $5.48. Analysts raised price targets, citing strong refining margins and cash flow. The company's leverage remains high, but cash generation supports dividends and debt reduction. DK's stock is technically in an uptrend, with support at $68 and resistance near $76.

stockstotrade.com2 min
AUG 9
$DKMed

Delek US Q2 Earnings Call Highlights

Delek US (NYSE: DK) Q2 earnings call covered refining margins, throughput guidance, and cash flow. Management said refined-product markets may take several quarters to normalize and that a less backwardated forward curve could lift realized crack spreads. Q3 throughput guided to 296,000-316,000 bpd, with Opex $220-$230M and D&A $110-$120M. Delek Logistics Partners reported ~$144M adjusted EBITDA and reaffirmed 2026 guidance of $520-$560M.

yahoo.com4 min
AUG 6
$DKMedAI 8/10

Delek US Holdings (DK) Q2 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q2 2026 net income of $170 million ($2.71/share) and adjusted net income of $344 million ($5.48/share). Adjusted EBITDA was $639 million, with RVO-adjusted EBITDA of $490 million and RVO-adjusted EPS of $3.64. Logistics segment adjusted EBITDA was a record $144 million. DKL full-year 2026 EBITDA guidance is $520 million to $560 million.

fool.com6 min
AUG 5
$DKMed

Delek Slides on Q2 Results

Delek US Holdings (NYSE: DK) reported Q2 ended June 30, 2026 net income of $169.5M ($2.71/share) and adjusted net income of $343.9M ($5.48/share). Adjusted EBITDA was $638.7M; excluding RVO impacts, adjusted EPS was $3.64 and adjusted EBITDA $490.1M. Delek Logistics posted adjusted EBITDA of $143.5M and is targeting $520-560M. Delek bought $20M of DK shares and paid $15.6M in dividends, declaring a $0.255 quarterly dividend.

baystreet.ca3 min